Glaukos Corporation
Price
OptionsOpen the Sheet →FilingsNewest: 8-K, Regulation FD disclosureAug 3 →InsidersNo open-market buys. 8 insiders sold $46.4M, 22 of 35 sales on a 10b5-1 plan.→HoldersBlackRock 16.2%Jupiter Topco 8.3%Vanguard Portfolio 5.6%→PeersClosest companies: OPK, BIIB, OCUL→
From the filings
Figures
- Revenue
- $612.8Mlast 12 months
- Net income
- −$188.0Mlast 12 months
- Operating cash flow
- −$8.8Mlast 12 months
- Cash and equivalents
- $114.5Mat the last balance sheet
- Shares outstanding
- 58.9M shareson issue